Dextran Sulfate
In clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
Rapamycin extenuates experimental colitis by modulating the gut microbiota.
Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development.
Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Gastroenterology2
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)1
- Cell death & disease1
- Gut microbes1
- Journal of gastroenterology and hepatology1
- Microbiome1
- Han D3
- Wang J3
- Zhang X3
- Pang J2
- Zhang G2
- Zhang S2
- Zhang Y2
- Ambat A1
- Oklahoma State University2
- State Key Laboratory of Animal Nutrition and Feeding2
- Albert Ludwigs University of Freiburg1
- College of Biomedicine and Health1
- College of Food Science and Technology1
- College of Veterinary Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Dextran Sulfate in the shared literature.
Studied across 3 of the same disease areas as Dextran Sulfate in the shared literature.
Studied across 3 of the same disease areas as Dextran Sulfate in the shared literature.
Studied across 3 of the same disease areas as Dextran Sulfate in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials